Sign up to access all valuation multiples
Mani Inc manufactures medical devices and dental instruments. It sells products in four categories: surgical instruments, ophthalmic instruments, suture needles, and dental instruments. Mani's surgical products include instruments such as staplers, vessel knives, and bone saws. Its ophthalmic instruments include a range of knives used during eye surgery and ophthalmic sutures. Mani's suture needles business includes a variety of taper point and cutting eyeless needles, which require suture attachment and sterilization by the customer, as well as stainless-steel eyed needles. The firm's dental instruments include endodontic instruments and accessories, root canal equipment, and finishing and polishing instruments.
1959
3.7K+
LTM Revenue $199M
LTM EBITDA $68.9M
$704M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Mani Inc. has a last 12-month revenue (LTM) of $199M and a last 12-month EBITDA of $68.9M.
In the most recent fiscal year, Mani Inc. achieved revenue of $192M and an EBITDA of $72.1M.
Mani Inc. expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Mani Inc. valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $199M | XXX | $192M | XXX | XXX | XXX |
| Gross Profit | $131M | XXX | $121M | XXX | XXX | XXX |
| Gross Margin | 66% | XXX | 63% | XXX | XXX | XXX |
| EBITDA | $68.9M | XXX | $72.1M | XXX | XXX | XXX |
| EBITDA Margin | 35% | XXX | 38% | XXX | XXX | XXX |
| EBIT | $53.3M | XXX | $56.5M | XXX | XXX | XXX |
| EBIT Margin | 27% | XXX | 29% | XXX | XXX | XXX |
| Net Profit | $37.6M | XXX | $42.4M | XXX | XXX | XXX |
| Net Margin | 19% | XXX | 22% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 29, 2025, Mani Inc.'s stock price is JPY 1237 (or $8).
Mani Inc. has current market cap of JPY 122B (or $821M), and EV of JPY 104B (or $704M).
See Mani Inc. trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $704M | $821M | XXX | XXX | XXX | XXX | $0.38 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 29, 2025, Mani Inc. has market cap of $821M and EV of $704M.
Mani Inc.'s trades at 3.6x EV/Revenue multiple, and 9.9x EV/EBITDA.
Equity research analysts estimate Mani Inc.'s 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Mani Inc. has a P/E ratio of 21.9x.
See valuation multiples for Mani Inc. and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $821M | XXX | $821M | XXX | XXX | XXX |
| EV (current) | $704M | XXX | $704M | XXX | XXX | XXX |
| EV/Revenue | 3.5x | XXX | 3.6x | XXX | XXX | XXX |
| EV/EBITDA | 10.2x | XXX | 9.9x | XXX | XXX | XXX |
| EV/EBIT | 13.2x | XXX | 12.7x | XXX | XXX | XXX |
| EV/Gross Profit | 5.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | 21.9x | XXX | 20.1x | XXX | XXX | XXX |
| EV/FCF | 30.1x | XXX | 84.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMani Inc.'s last 12 month revenue growth is 8%
Mani Inc.'s revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $17K for the same period.
Mani Inc.'s rule of 40 is 47% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Mani Inc.'s rule of X is 54% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Mani Inc. and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 35% | XXX | 37% | XXX | XXX | XXX |
| EBITDA Growth | 11% | XXX | 2% | XXX | XXX | XXX |
| Rule of 40 | 47% | XXX | 44% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 54% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $17K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 33% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Mani Inc. acquired XXX companies to date.
Last acquisition by Mani Inc. was XXXXXXXX, XXXXX XXXXX XXXXXX . Mani Inc. acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Mani Inc. founded? | Mani Inc. was founded in 1959. |
| Where is Mani Inc. headquartered? | Mani Inc. is headquartered in Japan. |
| How many employees does Mani Inc. have? | As of today, Mani Inc. has 3.7K+ employees. |
| Who is the CEO of Mani Inc.? | Mani Inc.'s CEO is Mr. Masahiko Saito. |
| Is Mani Inc. publicy listed? | Yes, Mani Inc. is a public company listed on TKS. |
| What is the stock symbol of Mani Inc.? | Mani Inc. trades under 7730 ticker. |
| When did Mani Inc. go public? | Mani Inc. went public in 2001. |
| Who are competitors of Mani Inc.? | Similar companies to Mani Inc. include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Mani Inc.? | Mani Inc.'s current market cap is $821M |
| What is the current revenue of Mani Inc.? | Mani Inc.'s last 12 months revenue is $199M. |
| What is the current revenue growth of Mani Inc.? | Mani Inc. revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Mani Inc.? | Current revenue multiple of Mani Inc. is 3.5x. |
| Is Mani Inc. profitable? | Yes, Mani Inc. is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Mani Inc.? | Mani Inc.'s last 12 months EBITDA is $68.9M. |
| What is Mani Inc.'s EBITDA margin? | Mani Inc.'s last 12 months EBITDA margin is 35%. |
| What is the current EV/EBITDA multiple of Mani Inc.? | Current EBITDA multiple of Mani Inc. is 10.2x. |
| What is the current FCF of Mani Inc.? | Mani Inc.'s last 12 months FCF is $23.4M. |
| What is Mani Inc.'s FCF margin? | Mani Inc.'s last 12 months FCF margin is 12%. |
| What is the current EV/FCF multiple of Mani Inc.? | Current FCF multiple of Mani Inc. is 30.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
